About 1 result found for searched term "ACT-660602" (0.132 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21323 | ACT-660602 | CXCR |
| ACT-660602 is an oral chemokine receptor CXCR3 antagonist with an IC50 of 204 nM. It is being developed for use in autoimmune diseases. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
